Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy (REVERSE-DBMD)

This study has suspended participant recruitment.
(As recommended by the DSMB.)
Johns Hopkins University
Information provided by (Responsible Party):
Kathryn Wagner, Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Identifier:
First received: July 22, 2010
Last updated: February 4, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):